Growth Metrics

Sanara MedTech (SMTI) Gains from Investment Securities (2016 - 2025)

Sanara MedTech's Gains from Investment Securities history spans 10 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 989.55% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $2.4 million, up 692.87%, while the annual FY2025 figure was $10218.0, 67.05% down from the prior year.
  • Gains from Investment Securities reached $2.4 million in Q4 2025 per SMTI's latest filing, up from $208414.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $4.4 million in Q4 2021 to a low of -$265654.0 in Q4 2024.
  • Average Gains from Investment Securities over 5 years is $461943.1, with a median of $112423.0 recorded in 2023.
  • The largest YoY upside for Gains from Investment Securities was 1153.83% in 2022 against a maximum downside of 104.35% in 2022.
  • A 5-year view of Gains from Investment Securities shows it stood at $4.4 million in 2021, then crashed by 104.35% to -$192043.0 in 2022, then skyrocketed by 161.92% to $118912.0 in 2023, then tumbled by 323.4% to -$265654.0 in 2024, then skyrocketed by 989.55% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Gains from Investment Securities are $2.4 million (Q4 2025), $208414.0 (Q3 2025), and $31013.0 (Q2 2025).